$15.41
0.74%
Nasdaq, Sep 02, 10:00 pm CET
ISIN
US74019L1070
Symbol
PRPO

Precipio, Inc. Stock price

$15.41
+0.90 6.18% 1M
+8.13 111.88% 6M
+9.87 178.10% YTD
+8.85 134.85% 1Y
-6.39 29.33% 3Y
-27.19 63.84% 5Y
-10,784.59 99.86% 10Y
-113,384.59 99.99% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
-0.11 0.74%

Key metrics

Basic
Market capitalization
$25.0m
Enterprise Value
$24.7m
Net debt
positive
Cash
$1.1m
Shares outstanding
1.5m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.2 | -
EV/Sales
1.2 | -
EV/FCF
43.2
P/B
2.0
Financial Health
Equity Ratio
71.2%
Return on Equity
-35.5%
ROCE
-18.1%
ROIC
-16.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$21.2m | -
EBITDA
$-1.3m | -
EBIT
$-2.6m | -
Net Income
$-1.8m | -
Free Cash Flow
$570.0k
Growth (TTM | estimate)
Revenue
27.0% | -
EBITDA
51.6% | -
EBIT
32.4% | -
Net Income
53.0% | -
Free Cash Flow
152.3%
Margin (TTM | estimate)
Gross
44.7%
EBITDA
-5.9% | -
EBIT
-12.3%
Net
-8.5% | -
Free Cash Flow
2.7%
More
EPS
$-1.1
FCF per Share
$0.4
Short interest
0.5%
Employees
57
Rev per Employee
$330.0k
Show more

Is Precipio, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Precipio, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Precipio, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Precipio, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Precipio, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
21 21
27% 27%
100%
- Direct Costs 12 12
15% 15%
55%
9.49 9.49
45% 45%
45%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
-1.25 -1.25
52% 52%
-6%
- Depreciation and Amortization 1.37 1.37
7% 7%
6%
EBIT (Operating Income) EBIT -2.62 -2.62
32% 32%
-12%
Net Profit -1.80 -1.80
53% 53%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Precipio, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precipio, Inc. Stock News

Neutral
Seeking Alpha
20 days ago
Precipio, Inc. (NASDAQ:PRPO ) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Ilan Danieli - Founder, President, CEO & Director Operator Welcome to the Precipio Q2 2025 Shareholder Update Conference Call. [Operator Instructions] Please note that this conference is being recorded.
Neutral
GlobeNewsWire
21 days ago
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today.
Neutral
GlobeNewsWire
about one month ago
NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET.
More Precipio, Inc. News

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Head office United States
CEO Ilan Danieli
Employees 57
Founded 1997
Website www.precipiodx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today